Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    9531324 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Phase I Trial of Recombinant Human Interleukin-10 (SCH 52000) in Patients With Wegener's Granulomatosis
Conditions: Vasculitis;   Wegener's Granulomatosis
Intervention: Drug: Interleukin-10

Indicates status has not been verified in more than two years